North America Infectious Disease Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Infectious Disease Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Infectious Disease Diagnostics Market Regional Analysis

6.2 North America Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)

6.3 North America Infectious Disease Diagnostics Market Forecast Analysis

7. North America Infectious Disease Diagnostics Market Analysis – by Product

7.1 Kits & Reagents

7.1.1 Overview
7.1.2 Kits & Reagents: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Software & Services

7.3.1 Overview
7.3.2 Software & Services: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Infectious Disease Diagnostics Market Analysis – by Technology

8.1 Biosensor-Based

8.1.1 Overview
8.1.2 Biosensor-Based: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Immunodiagnostics

8.2.1 Overview
8.2.2 Immunodiagnostics: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Molecular-Based Diagnostic Techniques

8.3.1 Overview
8.3.2 Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Clinical Biology

8.4.1 Overview
8.4.2 Clinical Biology: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Infectious Disease Diagnostics Market Analysis – by Application Type

9.1 Laboratory Testing and Point-of-Care Testing

9.1.1 Overview
9.1.2 Laboratory Testing and Point-of-Care Testing: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Infectious Disease Diagnostics Market Analysis – by Testing Type

10.1 Human Testing and Veterinary Testing

10.1.1 Overview
10.1.2 Human Testing and Veterinary Testing: North America Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Infectious Disease Diagnostics Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Infectious Disease Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Infectious Disease Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Infectious Disease Diagnostics Market Breakdown, by Product
11.2.1.1.2 US: North America Infectious Disease Diagnostics Market Breakdown, by Technology
11.2.1.1.3 US: North America Infectious Disease Diagnostics Market Breakdown, by Application Type
11.2.1.1.4 US: North America Infectious Disease Diagnostics Market Breakdown, by Testing Type

11.2.1.2 Canada: North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Product
11.2.1.2.2 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Technology
11.2.1.2.3 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Application Type
11.2.1.2.4 Canada: North America Infectious Disease Diagnostics Market Breakdown, by Testing Type

11.2.1.3 Mexico : North America Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Product
11.2.1.3.2 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Technology
11.2.1.3.3 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Application Type
11.2.1.3.4 Mexico : North America Infectious Disease Diagnostics Market Breakdown, by Testing Type

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Abbott Laboratories

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 ACON Laboratories Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Bio-Rad Laboratories Inc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bruker Corp

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Cardinal Health Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Danaher Corp

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 DiaSorin SpA

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 F. Hoffmann-La Roche Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Trinity Biotech Plc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Infectious Disease Diagnostics Market